Neuroendocrine Cancer Resistant to Chemotherapy, Only Shrinks to Clear After Adding ECCT and Surviving 5 Years
Mr. Roni’s right-neck mass grew rapidly after his diagnosis in early 2021, leaving him coughing, struggling to swallow and shivering at night. Biopsy findings described a poorly differentiated neuroendocrine cancer or diffuse non-Hodgkin lymphoma. CT imaging showed a mass nearly 10 cm wide pressing on major neck blood vessels, even after an initial six chemotherapy sessions.
Mr. Roni and his wife were reluctant to continue chemotherapy. After consulting the ECCT team, they agreed to combine use of the device with another course of chemotherapy because of the mass’s size. The account reports substantial shrinkage during that course, with a later PET scan showing a neck mass of around 2 to 3 cm after six months.
He then continued with ECCT alone. Roughly two years after starting, the neck lump was reported to have cleared, his weight had returned and his everyday condition was described as normal.